Alvotech (ALVO)

• Market cap: $3.97B
• 1 day: -0.53%
• 5 days: 6.39%
• 1 month: 12.86%
• 3 months: 6.99%
• 6 months: 7.52%
• Year to date: 15.85%
• 1 year: 15.85%
• 5 years: 17.61%
• 10 years: 17.61%

About: Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

Employees: 999

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

3% more funds holding

Funds holding: 31 [Q2] → 32 (+1) [Q3]

2% more capital invested

Capital invested by funds: $180M [Q2] → $184M (+$3.58M) [Q3]

0% more funds holding in top 10

Funds holding in top 10: 3 [Q2] → 3 (+0) [Q3]

0.19% less ownership

Funds ownership: 5.37% [Q2] → 5.19% (-0.19%) [Q3]

20% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 10